Oracle Investment Management INC Has Decreased Its Quidel Corp (QDEL) Position by $6.98 Million

Investors sentiment decreased to 1.15 in Q2 2019. Its down 0.27, from 1.42 in 2019Q1. It dived, as 22 investors sold QDEL shares while 43 reduced holdings. 20 funds opened positions while 55 raised stakes. 36.17 million shares or 2.10% more from 35.42 million shares in 2019Q1 were reported. Illinois-based Northern Corporation has invested 0.01% in Quidel Corporation (NASDAQ:QDEL). Putnam Invests Limited Liability Company holds 0.02% of its portfolio in Quidel Corporation (NASDAQ:QDEL) for 147,669 shares. Price T Rowe Inc Md invested 0.05% of its portfolio in Quidel Corporation (NASDAQ:QDEL). Zebra Capital Mngmt accumulated 9,081 shares. Mackenzie holds 5,611 shares or 0% of its portfolio. Gamco Et Al has invested 0.21% in Quidel Corporation (NASDAQ:QDEL). Moreover, Magnetar Financial Ltd has 0.05% invested in Quidel Corporation (NASDAQ:QDEL) for 43,485 shares. Jpmorgan Chase stated it has 0% in Quidel Corporation (NASDAQ:QDEL). First Trust Advsrs LP invested in 0.01% or 60,741 shares. Citadel Ltd Liability accumulated 11,227 shares. 7,214 are owned by Pitcairn. State Street Corporation has invested 0% in Quidel Corporation (NASDAQ:QDEL). 10,830 were accumulated by Metropolitan Life Ins New York. Bowling Portfolio Management Limited Liability Co reported 0.07% stake. Renaissance Techs Ltd Liability Co invested in 0.01% or 115,087 shares.

Oracle Investment Management Inc decreased its stake in Quidel Corp (QDEL) by 6.21% based on its latest 2019Q2 regulatory filing with the SEC. Oracle Investment Management Inc sold 118,294 shares as the company’s stock declined 7.87% . The hedge fund held 1.79 million shares of the in vitro & in vivo diagnostic substances company at the end of 2019Q2, valued at $105.90M, down from 1.90 million at the end of the previous reported quarter. Oracle Investment Management Inc who had been investing in Quidel Corp for a number of months, seems to be less bullish one the $2.78B market cap company. The stock decreased 1.84% or $1.26 during the last trading session, reaching $67.16. About 313,070 shares traded or 46.54% up from the average. Quidel Corporation (NASDAQ:QDEL) has declined 9.66% since September 13, 2018 and is downtrending. It has underperformed by 9.66% the S&P500.

Analysts await Quidel Corporation (NASDAQ:QDEL) to report earnings on November, 5. They expect $0.59 EPS, up 9.26 % or $0.05 from last year’s $0.54 per share. QDEL’s profit will be $24.45M for 28.46 P/E if the $0.59 EPS becomes a reality. After $0.30 actual EPS reported by Quidel Corporation for the previous quarter, Wall Street now forecasts 96.67 % EPS growth.

More notable recent Quidel Corporation (NASDAQ:QDEL) news were published by: which released: “Here’s Why You Should Hold on to Medidata (MDSO) Stock Now – Nasdaq” on June 03, 2019, also with their article: “RSI Alert: Quidel (QDEL) Now Oversold – Nasdaq” published on May 14, 2019, published: “Quidel (QDEL) Misses Q1 Earnings and Revenue Estimates – Yahoo Finance” on May 08, 2019. More interesting news about Quidel Corporation (NASDAQ:QDEL) were released by: and their article: “Quidel (QDEL) Presents At 37th Annual J.P. Morgan Healthcare Conference – Slideshow – Seeking Alpha” published on January 10, 2019 as well as‘s news article titled: “Quidel up 5% on supposed appeal win against Beckman – Seeking Alpha” with publication date: August 29, 2019.

Quidel Corporation (NASDAQ:QDEL) Ratings Coverage

Among 2 analysts covering Quidel (NASDAQ:QDEL), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Quidel has $77 highest and $74 lowest target. $75.50’s average target is 12.42% above currents $67.16 stock price. Quidel had 3 analyst reports since March 18, 2019 according to SRatingsIntel. The rating was maintained by Barclays Capital on Monday, March 18 with “Overweight”. The stock has “Strong Buy” rating by Raymond James on Monday, April 15.

Quidel Corporation (NASDAQ:QDEL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.